Manon Dekeyser
Overview
Explore the profile of Manon Dekeyser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dekeyser M, de Goer de Herve M, Hendel-Chavez H, Lhotte R, Scriabine I, Bargiel K, et al.
Kidney Int Rep
. 2024 Aug;
9(8):2498-2513.
PMID: 39156165
Introduction: BK polyomavirus-associated nephropathy (BKPyVAN) is a significant complication in kidney transplant recipients (KTRs), associated with a higher level of plasmatic BK polyomavirus (BKPyV) replication and leading to poor graft...
2.
de Goer de Herve M, Dekeyser M, Hendel-Chavez H, Maillart E, Labeyrie C, Adams D, et al.
Front Immunol
. 2024 Aug;
15:1416074.
PMID: 39086476
Introduction: Progressive Multifocal Leukoencephalopathy (PML) is a rare and deadly demyelinating disease caused by JC virus (JCV) replication in the central nervous system. PML occurs exclusively in patients with severe...
3.
Rostoker G, Dekeyser M, Francisco S, Loridon C, Griuncelli M, Languille-Llitjos E, et al.
EBioMedicine
. 2023 Dec;
99:104929.
PMID: 38128412
Background: Iron overload due to the excessive use of parenteral iron in haemodialysis is now an increasingly recognised clinical issue. Before erythropoiesis-stimulating agents (ESA) were introduced, a specific feature of...
4.
Herr F, Dekeyser M, Le Pavec J, Desterke C, Chiron A, Bargiel K, et al.
Pharmaceutics
. 2023 Apr;
15(4).
PMID: 37111784
Calcineurin inhibitors have improved graft survival in solid-organ transplantation but their use is limited by toxicity, requiring a switch to another immunosuppressor in some cases. Belatacept is one option that...
5.
Wiedemann A, Pellaton C, Dekeyser M, Guillaumat L, Dechenaud M, Krief C, et al.
Front Med (Lausanne)
. 2022 Sep;
9:978764.
PMID: 36072955
Immunocompromised patients have a high risk of death from SARS-CoV-2 infection. Vaccination with an mRNA vaccine may protect these patients against severe COVID-19. Several studies have evaluated the impact of...
6.
Dekeyser M, Taupin J, Elias M, Ichai P, Herr F, Boudon M, et al.
Front Med (Lausanne)
. 2022 Sep;
9:949833.
PMID: 36072942
Background: Acute rejection rate is low after simultaneous liver-kidney transplantation (SLKT), leading some groups to minimize immunosuppressive (IS) regimens. However, the impact of preformed (pDSA) or donor-specific antibodies (dnDSA) on...
7.
Herr F, Desterke C, Bargiel K, Vernochet A, Vanhove B, Vadanici R, et al.
Am J Transplant
. 2021 Aug;
22(2):489-503.
PMID: 34431219
Belatacept was developed to replace calcineurin inhibitors in kidney transplantation. Its use is associated with better kidney transplant function, a lower incidence of anti-donor antibodies and higher graft survival. However,...
8.
Ferlicot S, Jamme M, Gaillard F, Oniszczuk J, Couturier A, May O, et al.
Nephrol Dial Transplant
. 2021 Feb;
PMID: 33576823
We report a multicentric retrospective case series of patients with COVID-19 who developed acute kidney injury and/or proteinuria and underwent a kidney biopsy in the Paris and its metropolitan area....
9.
Tortonese S, Scriabine I, Anjou L, Loens C, Michon A, Benabdelhak M, et al.
Kidney Int Rep
. 2020 Aug;
5(9):1535-1544.
PMID: 32838082
Introduction: Coronavirus disease 2019 (COVID-19) represents a serious threat to patients on maintenance dialysis. The clinical setting, mortality rate, and prognostic factors in these patients have not been well established....
10.
Dekeyser M, Ladriere M, Audonnet S, Frimat L, Bittencourt M
Kidney Int Rep
. 2017 Nov;
2(3):486-492.
PMID: 29142976
No abstract available.